Table 5.
Hazard ratios (HRs)a and 95% confidence intervals for the association between MetS and breast cancer mortality by breast cancer subtype γ
ER+/PR+ | ER+/PR− | ER−/PR− | |
---|---|---|---|
N (Deaths)b | 2,995 (169) | 587 (58) | 619 (89) |
MetSδ | |||
Crude | 1.87 (0.78, 4.49) | 3.10 (0.63, 15.43) | 0.62 (0.17, 2.30) |
Adjusted§ | 1.28 (0.52, 3.16) | 1.89 (0.36,10.05) | 0.44 (0.11, 1.75) |
Components | |||
High WC | 1.15 (0.72, 1.84) | 1.11 (0.52, 2.33) | 1.21 (0.58, 2.55) |
High Cholesterol | 1.21 (0.90, 1.66) | 1.53 (0.89, 2.63) | 1.02 (0.66, 1.56) |
High blood pressure | 1.16 (0.85, 1.60) | 1.25 (0.73, 2.14) | 1.09 (0.70, 1.70) |
High fasting glucose | 1.72 (1.00, 2.96) | 0.80 (0.24, 2.64) | 1.70 (0.84, 3.46) |
Number of MetS Components | |||
0(Ref) | 1.00 | 1.00 | 1.00 |
1 | 1.18 (0.59, 2.35) | 1.86 (0.54, 6.40) | 0.66 (0.30, 1.45) |
2 | 1.91 (0.94, 3.88) | 2.39 (0.65, 8.72) | 0.97 (0.42, 2.25) |
3+ | 1.23 (0.47, 3.22) | 2.05 (0.38, 10.96) | 0.50 (0.13, 2.03) |
Crude model included MetS and age only.
Models were adjusted for age, race, BMI, education, region, physical activity, smoking, and marital status
Death, number of those who died of breast cancer; N=sample size
The reference category was women without any components of MetS.
ER and PR status only due to limited sample sizes on HER2 receptor status
Abbreviations: ER, estrogen receptor; MetS, metabolic syndrome; PR, progesterone receptor; Ref, reference; WC, waist circumference.
Bold indicates a statistically significant value.